node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
APOA1 | APOA2 | ENSPANP00000006074 | ENSPANP00000015095 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Apolipoprotein A-II | 0.997 |
APOA1 | APOB | ENSPANP00000006074 | ENSPANP00000017551 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Apolipoprotein B | 0.981 |
APOA1 | APOC1 | ENSPANP00000006074 | ENSPANP00000019552 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-mi [...] | 0.754 |
APOA1 | APOC2 | ENSPANP00000006074 | ENSPANP00000019549 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapolipoprotein C-II and apolipoprotein C-II can activate lipoprotein lipase | 0.945 |
APOA1 | APOC3 | ENSPANP00000006074 | ENSPANP00000010600 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Apolipoprotein C-III | 0.978 |
APOA1 | APOC4 | ENSPANP00000006074 | ENSPANP00000019551 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Apolipoprotein c-iv; May participate in lipoprotein metabolism | 0.496 |
APOA1 | APOE | ENSPANP00000006074 | ENSPANP00000019553 | Papio anubis apolipoprotein A-I (APOA1), mRNA | APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) [...] | 0.959 |
APOA1 | CETP | ENSPANP00000006074 | ENSPANP00000012837 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Cholesteryl ester transfer protein, plasma; Involved in the transfer of neutral lipids, including cholesteryl ester and triglyceride, among lipoprotein particles. Allows the net movement of cholesteryl ester from high density lipoproteins/HDL to triglyceride-rich very low density lipoproteins/VLDL, and the equimolar transport of triglyceride from VLDL to HDL | 0.852 |
APOA1 | LCAT | ENSPANP00000006074 | ENSPANP00000012215 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Phosphatidylcholine-sterol acyltransferase; Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines. Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-c [...] | 0.997 |
APOA1 | NR1H3 | ENSPANP00000006074 | ENSPANP00000012006 | Papio anubis apolipoprotein A-I (APOA1), mRNA | Nuclear receptor subfamily 1, group H, member 3 | 0.859 |
APOA2 | APOA1 | ENSPANP00000015095 | ENSPANP00000006074 | Apolipoprotein A-II | Papio anubis apolipoprotein A-I (APOA1), mRNA | 0.997 |
APOA2 | APOB | ENSPANP00000015095 | ENSPANP00000017551 | Apolipoprotein A-II | Apolipoprotein B | 0.944 |
APOA2 | APOC1 | ENSPANP00000015095 | ENSPANP00000019552 | Apolipoprotein A-II | Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-mi [...] | 0.659 |
APOA2 | APOC2 | ENSPANP00000015095 | ENSPANP00000019549 | Apolipoprotein A-II | Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapolipoprotein C-II and apolipoprotein C-II can activate lipoprotein lipase | 0.816 |
APOA2 | APOC3 | ENSPANP00000015095 | ENSPANP00000010600 | Apolipoprotein A-II | Apolipoprotein C-III | 0.958 |
APOA2 | APOC4 | ENSPANP00000015095 | ENSPANP00000019551 | Apolipoprotein A-II | Apolipoprotein c-iv; May participate in lipoprotein metabolism | 0.428 |
APOA2 | APOE | ENSPANP00000015095 | ENSPANP00000019553 | Apolipoprotein A-II | APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) [...] | 0.933 |
APOA2 | CETP | ENSPANP00000015095 | ENSPANP00000012837 | Apolipoprotein A-II | Cholesteryl ester transfer protein, plasma; Involved in the transfer of neutral lipids, including cholesteryl ester and triglyceride, among lipoprotein particles. Allows the net movement of cholesteryl ester from high density lipoproteins/HDL to triglyceride-rich very low density lipoproteins/VLDL, and the equimolar transport of triglyceride from VLDL to HDL | 0.653 |
APOA2 | LCAT | ENSPANP00000015095 | ENSPANP00000012215 | Apolipoprotein A-II | Phosphatidylcholine-sterol acyltransferase; Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines. Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-c [...] | 0.602 |
APOA2 | NR1H3 | ENSPANP00000015095 | ENSPANP00000012006 | Apolipoprotein A-II | Nuclear receptor subfamily 1, group H, member 3 | 0.733 |